Trade Summary

4 days ago, Fitzpatrick Jennifer, serving as Chief Legal Officer at Sionna Therapeutics, Inc. (SION), sold 10,250 shares at $43.60 per share, for a total transaction value of $446,862.08.

This sale represents a 100.00% decrease in Fitzpatrick Jennifer's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 4:38 PM ET, 1 day after the trade was made.

Sionna Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.